Blocking of the co-stimulatory 2B4 receptor, which is compromised in one primary immunodeficiency (Duncan disease or XLP1) that predisposes for uncontrolled EBV infection, resulted in the loss of CD8+ T cell-mediated immune control and elevated viral loads as well as increased tumor frequency (43). The gene discussed is CD8A; the disease is Epstein-Barr virus infection.